Re: Resverlogix to Present at the Clinical Trials on Alzheimer's Disease Congress 2019
posted on
Dec 02, 2019 10:55AM
iconoclast, that is precisely the thought jumped into my head when I read that statement.
Exciting science but not quite there yet so lots of trial work to come. We'll see. I really hope the results are significant enough for the FDA to give clinical consideration as is to this target or to a more refined target.
Toinv